In Vitro Characterization of Botulinum Toxin Types A, C and D Action on Human Tissues: Combined Electrophysiologic, Pharmacologic and Molecular Biologic Approaches

作者: L. G. Gomella , J. A. Coffield , L. L. Simpson , J. Carlson , R.-d. Zhang

DOI:

关键词:

摘要: Human exposure to botulinum toxin typically occurs in two settings: 1) as an etiologic agent the disease botulism and 2) a therapeutic for treatment of dystonia. Epidemiologic studies on suggest that human nervous system is susceptible five serotypes (A, B, E, F G) resistant (C D). In past, these epidemiologic findings have been used basis selecting should be tested agents data utilized because there are no neurotoxin action isolated nerves. present study, electrophysiologic techniques were monitor effects neuromuscular transmission surgically excised pyramidalis muscles, ligand binding done detect characterize receptors nerve membrane preparations, molecular biologic isolate sequence gene encodes substrate neurotoxin. The results demonstrated stable resting potentials (−61.5 mV; S.E.M. ± 0.7) maintained individual fibers muscle up 6 hr at 33°C. rate spontaneous miniature endplate was low physiologic solution (0.14 sec −1 ) but increased response elevations extracellular potassium concentration. keeping with findings, type A (10 −8 M) paralyzed preparations ( ca. 90 min). contrast serotype C also tissues 65 Iodinated displayed high-affinity (serotype site: K d = 0.3 nM, B max 0.78 pmol/mg protein; 1.96 8.9 protein). addition, found encode polypeptides substrates types (synaptosomal-associated protein M r 25,000) (syntaxin 1A). These important implications bearing on: development administration vaccines against testing

参考文章(47)
J. Blasi, E.R. Chapman, S. Yamasaki, T. Binz, H. Niemann, R. Jahn, Botulinum neurotoxin C1 blocks neurotransmitter release by means of cleaving HPC-1/syntaxin. The EMBO Journal. ,vol. 12, pp. 4821- 4828 ,(1993) , 10.1002/J.1460-2075.1993.TB06171.X
A Khalique, W S Monkhouse, Variations in the composition of the human rectus sheath: a study of the anterior abdominal wall. Journal of Anatomy. ,vol. 145, pp. 61- 66 ,(1986)
Lance L. Simpson, Botulinum neurotoxin and tetanus toxin Academic Press. ,(1989)
Mark Hallett, Joseph Jankovic, Therapy with botulinum toxin M. Dekker. ,(1994)
Lance L Simpson, James J Schmidt, John L Middlebrook, [12] Isolation and characterization of the Botulinum neurotoxins Methods in Enzymology. ,vol. 165, pp. 76- 85 ,(1988) , 10.1016/S0076-6879(88)65015-4
T. Binz, J. Blasi, S. Yamasaki, A. Baumeister, E. Link, T.C. Südhof, R. Jahn, H. Niemann, Proteolysis of SNAP-25 by types E and A botulinal neurotoxins Journal of Biological Chemistry. ,vol. 269, pp. 1617- 1620 ,(1994) , 10.1016/S0021-9258(17)42071-0
B. Poulain, S. Mochida, U. Weller, B. Högy, E. Habermann, J.D. Wadsworth, C.C. Shone, J.O. Dolly, L. Tauc, Heterologous combinations of heavy and light chains from botulinum neurotoxin A and tetanus toxin inhibit neurotransmitter release in Aplysia. Journal of Biological Chemistry. ,vol. 266, pp. 9580- 9585 ,(1991) , 10.1016/S0021-9258(18)92859-0
P Polverino de Laureto, W S Trimble, G Schiavo, G Milan, C Montecucco, C Malizio, E A Johnson, H Sugiyama, Botulinum G neurotoxin cleaves VAMP/synaptobrevin at a single Ala-Ala peptide bond. Journal of Biological Chemistry. ,vol. 269, pp. 20213- 20216 ,(1994) , 10.1016/S0021-9258(17)31976-2
B Poulain, J D F Wadsworth, C C Shone, S Mochida, S Lande, J Melling, J O Dolly, L Tauc, Multiple domains of botulinum neurotoxin contribute to its inhibition of transmitter release in Aplysia neurons. Journal of Biological Chemistry. ,vol. 264, pp. 21928- 21933 ,(1989) , 10.1016/S0021-9258(20)88274-X
Lura C. Williamson, Jane L. Halpern, Cesare Montecucco, J. Edward Brown, Elaine A. Neale, Clostridial Neurotoxins and Substrate Proteolysis in Intact Neurons BOTULINUM NEUROTOXIN C ACTS ON SYNAPTOSOMAL-ASSOCIATED PROTEIN OF 25 kDa Journal of Biological Chemistry. ,vol. 271, pp. 7694- 7699 ,(1996) , 10.1074/JBC.271.13.7694